Dr. Md. Kamrul Hasan

Hematology

Worked as Resident Medical Officer (RMO) at Intensive Care Unit (ICU), Lab Aid Specialized Hospital, Dhanmondi, Dhaka from Jan, 2012 to July 2012
Worked as Consultant/ Specialist of Hematology at Ahsania Mission Cancer and General Hospital, Dhaka, Bangladesh from March, 2019 to February, 2020
Worked as Consultant of Hematology at Mediscan Imaging Center, Kishoreganj, Dhaka, Bangladesh from March, 2020 to July, 2022
Worked as Lecturer at Shaheed Syed Nazrul Islam Medical College, Kishoreganj, Bangladesh from May, 2019 to July, 2022
Worked as Senior specialist at Evercare Hospital Dhaka, Bangladesh from August, 2022 to 10th August 2024
Worked as Attending consultant at Evercare Hospital Dhaka, Bangladesh from January, 2023 to 10th August, 2024
Worked as Associate Consultant (Hematology) at Ahsania Mission Cancer and General Hospital, Uttara, Dhaka from 17th August, 2024 to present.

BCPS Course at Department of Hematology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.
FCPS (Hematology) Training (03-years) in Internal medicine & Hematology (Clinical and Laboratory)

Islam MN, Biswas AR, Nazneen H, Chowdhury N, Alam M, Banik J, Hassan MK, et al. Clinical profile and demographic characteristics of moderate and severe hemophilia patients in a tertiary care hospital of Bangladesh. 2022;7:1–10. DOI: https://doi.org/10.1186/s13023-022-02413-7
Chowdhury FA, Islam MF, Prova MT, Khatun M, Sharmin I, Islam KM, Hassan MK, et al. Association of hyperlipidemia with breast cancer in Bangladeshi women. Lipids Health Dis. 2021;20(1):1–9. DOI: 10.1186/s12944-021-01480-2
Sumi SP, M NAAA, Alam J, Tayab A, Hasan J, Hassan MK. Frequency of nutritional rickets among suspected rickets cases in Dhaka Shishu (Children) hospital, Sher-e-Bangla Nagar, Dhaka. Int J Recent Sci Res. 2018;9(02):24447–51. DOI: http://dx.doi.org/10.24327/ijrsr.2018.0902.1663
Chowdhury N, Kabir A, Islam MM, Das S, Wasim M, Karim MN, Alam MM, Islam MN, Banik J, Fardous J, Hassan MK. "Outcome of Induction Chemotherapy with the Berlin-Frankfurt-Munster-95 Regimen in Acute Lymphoblastic Leukemia Patients: A Quasi-Experimental Study." Mymensingh medical journal: MMJ 34.2 (2025): 412-419.